AJ Lanigan: Certainly. In Fact, pharma businesses are generating big revenue with therapies like Keytruda and Opdivo that offer with PD-1 and PD-L1. Listed here’s the super cool section: think about checkpoints as website traffic indicators. You don’t want an immune program that’s running wild just like a freight train waiting for link from Social Bookmarking